{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:32:17Z","timestamp":1761183137132,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/bf02355127","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T18:23:48Z","timestamp":1144347828000},"page":"268-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emergence of Nonalbicans Candida Species in Immunocompromised Leukemia Patients during Fluconazole Treatment"],"prefix":"10.1016","volume":"2","author":[{"given":"Kunio","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/BF02355127_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02350844","article-title":"Clinical evaluation of monotherapy with cefpirome for infections complicating hematological disorders","volume":"2","author":"Yano","year":"1996","journal-title":"J Infect Chemother"},{"key":"10.1007\/BF02355127_bib0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1007\/BF02355127_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/33.2.309","article-title":"The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients","volume":"33","author":"Chandrasekar","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/BF02355127_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","article-title":"The prophylactic use of low-dose amphotericin B in bone marrow transplant patients","volume":"97","author":"Riley","year":"1994","journal-title":"Am J Med"},{"key":"10.1007\/BF02355127_bib0025","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1007\/BF02355127_bib0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/163.2.420","article-title":"Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis [letter]","volume":"163","author":"McIlroy","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1007\/BF02355127_bib0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/00365549209061349","article-title":"Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia","volume":"24","author":"Abrahamsen","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"10.1007\/BF02355127_bib0040","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM199110313251814","article-title":"Fluconazole and Candida krusei fungemia (letter)","volume":"325","author":"Persons","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1007\/BF02355127_bib0045","first-page":"892","article-title":"Prophylactic fluconazole and Candida krusei infections (letter)","volume":"326","author":"Schuler","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1007\/BF02355127_bib0050","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/clinids\/12.Supplement_3.S369","article-title":"Prophylaxis of oropharyngeal-candidiasis with fluconazole","volume":"12","author":"Samonis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1007\/BF02355127_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1007\/BF02355127_bib0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","year":"1989","journal-title":"Am J Med"},{"key":"10.1007\/BF02355127_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-113-3-177","article-title":"Fluconazole, a new antifungal, agent","volume":"113","author":"Galgiani","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1007\/BF02355127_bib0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/106002809402800219","article-title":"Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole","volume":"28","author":"Grasela","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1007\/BF02355127_bib0075","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1007\/BF02355127_bib0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-120-11-199406010-00003","article-title":"Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B","volume":"120","author":"Menichetti","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1007\/BF02355127_bib0085","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/BF02355127_bib0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.39.4.868","article-title":"In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp","volume":"39","author":"Wardle","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/BF02355127_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1099\/00207713-46-1-35","article-title":"Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua","volume":"46","author":"Essayag","year":"1996","journal-title":"Int J Syst Bacteriol"},{"key":"10.1007\/BF02355127_bib0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/clinids\/20.2.342","article-title":"Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole","volume":"20","author":"Iwen","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1007\/BF02355127_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000239322","article-title":"Candida glabrata, Candida krusei, nonalbicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989\u20131993: no association with the use of fluconazole","volume":"41","author":"Kunova","year":"1995","journal-title":"Chemotherapy"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X9671526X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X9671526X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/BF02355127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:07:35Z","timestamp":1761160055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X9671526X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996]]}},"alternative-id":["S1341321X9671526X"],"URL":"https:\/\/doi.org\/10.1007\/bf02355127","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[1996]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of Nonalbicans Candida Species in Immunocompromised Leukemia Patients during Fluconazole Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/BF02355127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}